Funding

DARPA RESTORE program targets neuromodulation for rapid sleep efficiency recovery in military populations

DARPA's Biological Technologies Office has launched the RESTORE program, focused on non-invasive multimodal brain stimulation to accelerate recovery from sleep deprivation. The program targets operational military environments where sleep loss degrades cognitive performance and decision-making...

NIH BRAIN Initiative expands funding for precision molecular circuit therapies targeting psychiatric disorders

The NIH BRAIN Initiative has announced expanded funding for precision molecular circuit therapies — combining optogenetics, chemogenetics, and gene therapy vectors to modulate specific neural circuits implicated in treatment-resistant psychiatric disorders including depression, OCD, and PTSD...

Longevium Raises $7M to Build AI-Powered Longevity Research Lab in Dubai

Juvenescence Raises $76M Series B-1 for AI-Led Longevity Drug Development

DARPA BTO Funding Opportunity: Peripheral Nerve Interfaces for Autonomic Modulation

DARPA's Biological Technologies Office is soliciting proposals for research into peripheral nerve interfaces and autonomic nervous system modulation for physiological resilience and cognitive performance.

NIH BRAIN Initiative Administrative Supplements for Neuromodulation Research 2026

The NIH BRAIN Initiative is accepting administrative supplement applications for existing grantees to integrate neuromodulation approaches into ongoing research. Supplements up to $300,000 in direct costs are available.

NSF Convergence Accelerator: Mind-Body Biomarkers for Mental Health

The NSF Convergence Accelerator has announced a new track focused on mind-body biomarkers, supporting multidisciplinary teams developing validated, scalable biomarker platforms bridging subjective mental health assessments with objective physiological measurements.

SOND Raises $7M for AI-Powered Sleep Earbuds

An in-ear wearable that monitors your sleep stages and intervenes in real-time to improve sleep quality. Just raised $7M.

Sychedelic Raises $3.5M for Closed-Loop Brain Stimulation Headphones

A new startup is cramming tDCS, binaural beats, and HRV biofeedback into a pair of headphones. They just raised $3.5M to ship it.

Universal Brain Secures FDA Clearance with $7.9M Seed Backing for EEG Diagnostics

Backed by $7.9M in seed funding, Universal Brain has achieved FDA 510(k) clearance for its dry-electrode EEG platform that provides objective psychiatric assessments in under 5 minutes — validating the investment in objective mental health diagnostics.

Ognomy Sleep Raises $20M Series A for Virtual Sleep Apnea Diagnosis Platform

Ognomy Sleep raised a $20M Series A for its telehealth platform that provides end-to-end virtual sleep apnea diagnosis and treatment — from at-home testing to CPAP prescription — without ever visiting a sleep lab.

WHOOP Raised $575 Million — and Mayo Clinic Is an Investor

WHOOP's latest funding round included Mayo Clinic and Abbott Labs as investors. When hospitals invest in wearables, the category stops being about fitness and starts being about healthcare infrastructure.

Neurosoft Bioelectronics Closes $7.5M Oversubscribed Seed Round

The BCI startup developing stretchable, scalable neural interfaces closed an oversubscribed $7.5M seed round. Their flexible electrode technology could make brain-computer interfaces more practical for long-term use.

Nervonik Raises $52.5M Series B for Neuromodulation Device

The neuromodulation startup closed a $52.5 million Series B to advance its non-invasive nerve stimulation platform. The device targets chronic pain and neurological disorders through peripheral nerve modulation.

ANEUVO Raises $22M Series C for Non-Invasive Spinal Cord Stimulation

ANEUVO closed a $22M Series C for its non-invasive spinal cord stimulation platform that treats chronic pain without implanted electrodes — using transcutaneous technology that patients can self-administer at home.

Blossom Health Raises $20M for AI-Powered Psychiatric Assessment

The mental health startup raised $20M to scale its AI platform that helps psychiatrists with diagnostic assessment and treatment planning. Blossom's system analyzes clinical conversations to surface diagnostic insights.

Eleos Health Raises $60M Series C for Clinical AI in Mental Health

The behavioral health AI company raised $60M to scale its clinician-embedded platform. Eleos uses session analysis to improve care quality and reduce documentation burden for therapists and psychiatrists.

Science Corp. Raises $230M to Scale Neural Interface Platform

Science Corp. closed a $230 million round in early 2026 to advance its neural interface technology aimed at restoring vision and treating neurological conditions, building on its earlier $104M convertible note.

Merge Labs Raises $252M Seed Round for Brain-Computer Interface

One of the largest seed rounds in neurotechnology history. Merge Labs, backed by OpenAI and Bain Capital, is building next-generation brain-computer interfaces that could transform how humans interact with technology.

Eight Sleep Raises $50M to Scale AI-Powered Smart Mattress Technology

Eight Sleep secured $50M in growth equity to expand its AI-powered Pod mattress cover that dynamically adjusts bed temperature throughout the night based on biometric data — optimizing sleep architecture without wearables.

Compass Pathways Raises $350M Following Breakthrough Psilocybin Phase 3 Data

Compass Pathways raised approximately $350M through public offerings after releasing pivotal Phase 3 data for COMP360 psilocybin therapy in treatment-resistant depression — potentially the first psychedelic therapy to receive FDA approval.

NeuroBionics Raises $10M Seed for Neural Prosthetics

The neural prosthetics startup raised $10M to develop next-generation brain-controlled prosthetic limbs. Their technology aims to restore natural movement and sensation for amputees through direct neural interfaces.

Cognito Therapeutics Raises $105M Series C for Alzheimer's Neurostimulation Therapy

Cognito Therapeutics closed $105M to advance its gamma-frequency sensory stimulation therapy for Alzheimer's disease — a non-invasive approach that uses light and sound to drive neural oscillations associated with cognitive function.

Talkiatry Closes $210M Series D to Scale AI-Powered Psychiatry

The telepsychiatry platform raised $210M to expand its AI copilot for clinicians and scale psychiatric care delivery. Talkiatry now serves over 1 million patients across 50 states.

Click Therapeutics Secures $50M Series D for Prescription Digital Therapeutics

The company developing FDA-authorized prescription digital therapeutics raised $50M to advance its pipeline. Click's software-based treatments target neurological and psychiatric conditions through evidence-based behavioral interventions.

Ambros Therapeutics Raises $125M Series A for CNS Small Molecule Platform

Ambros Therapeutics raised $125M in one of the largest Series A rounds in CNS drug development, building a pipeline of brain-penetrant small molecules targeting neuropsychiatric and neurodegenerative conditions.

NextSense Raises $16M Series A for In-Ear EEG Brain Health Monitoring

NextSense secured a $16M Series A for its in-ear EEG earbuds that monitor brain activity during sleep — building a platform for early detection of neurological conditions from Alzheimer's to epilepsy.

Oura Health Raises $900M Series E to Expand Smart Ring Platform

Finnish wearable company Oura raised a massive $900M Series E, pushing its valuation to $5.2B. The company's smart ring tracks sleep, heart rate, temperature, and activity — becoming a cornerstone of the biometric wearable movement.

Synchron Raises $200M Series D for Minimally Invasive Brain-Computer Interface

Synchron raised $200M to advance its Stentrode BCI — a brain-computer interface implanted through blood vessels rather than open brain surgery. The device lets paralyzed patients control computers with thought alone.

SetPoint Medical Raises $140M for Implantable Bioelectronic Medicine

SetPoint Medical secured $140M in growth equity for its implantable vagus nerve stimulator that treats autoimmune diseases by hacking the inflammatory reflex — replacing immunosuppressant drugs with electrical signals.

Draig Therapeutics Emerges with $140M to Develop CNS Gene Therapies

Draig Therapeutics launched with a combined $140 million seed and Series A to develop next-generation gene therapies targeting central nervous system disorders, backed by leading biotech VCs.

Phantom Neuro Secures $19M Series A for Prosthetic Nervous System Interface

Phantom Neuro raised a $19M Series A to develop its peripheral nerve interface technology that gives amputees natural sensory feedback from prosthetic limbs — restoring the feeling of touch.

Elemind Raises $12M Seed to Build Brain-Responsive Sleep Technology

Elemind Technologies emerged from stealth with $12M in seed funding for its wearable headband that uses real-time EEG to detect brain patterns and deliver personalized acoustic stimulation — designed to help users fall asleep faster without drugs.